Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00748618 · ClinicalTrials.gov registry record · NA
Vitamin D Replacement After Kidney Transplant
A NA study of Vitamin D Deficiency and Kidney Transplantation, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT00748618: Completed NA study of Vitamin D Deficiency and Kidney Transplantation, sponsored by University of Nebraska.
NCT00748618 is a NA study of Vitamin D Deficiency and Kidney Transplantation that has completed, run by University of Nebraska. The registered enrollment target is 116 participants, below the 273-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00748618, a NA study of Vitamin D Deficiency and Kidney Transplantation, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitamin D deficiency accelerates vascular risk progression after kidney transplant.
Primary Outcome
The 6 month change (6 month - Baseline) was compared between the two treatment arms of vitamin D supplements for normalizing vitamin D concentrations. Higher change values indicate improvement in vitamin D levels.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Standard vitamin D3 treatment
- DIETARY_SUPPLEMENT High dose vitamin D3 treatment
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2008-10-01 |
| Est. Completion | 2023-06-08 |
| Phase | NA |
What the finished NCT00748618 record still lists
NCT00748618 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 273-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Vitamin D Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Standard vitamin D3 treatment is the first listed.
NCT00748618 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT00748618 about?
NCT00748618 is a clinical study titled "Vitamin D Replacement After Kidney Transplant". Vitamin D deficiency accelerates vascular risk progression after kidney transplant.
What is the current status of trial NCT00748618?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2008-10-01. Estimated completion is 2023-06-08.
What conditions does trial NCT00748618 study?
This clinical trial studies the following conditions: Vitamin D Deficiency, Kidney Transplantation.
What interventions are being tested in trial NCT00748618?
The interventions under investigation include: Standard vitamin D3 treatment (DIETARY_SUPPLEMENT), High dose vitamin D3 treatment (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00748618?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00748618 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin D Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00748618's enrollment target sits among peer trials
116 13th of 48 higher than 36 of 48 other Vitamin D Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vitamin D Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight
RECRUITING · NA
-
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
RECRUITING · NA
-
ViDES Trial (Vitamin D Extra Supplementation)
ACTIVE NOT RECRUITING · NA
-
Vitamin D Sulfates in Breastmilk
ACTIVE NOT RECRUITING · NA
-
Vitamin D and Adipose Tissue Inflammation
COMPLETED · NA
-
Vitamin D Levels and Vitamin D Education in Geriatric Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI